Trademark: 97627546
Word
CBM
Status
Dead
Status Code
606
Status Date
Monday, July 1, 2024
Serial Number
97627546
Mark Type
4
Filing Date
Tuesday, October 11, 2022
Published for Opposition
Tuesday, October 3, 2023
Abandoned Date
Monday, July 1, 2024

Trademark Owner History

Classifications
40 Manufacturing services for others in the fields of pharmaceutical preparations, biopharmaceutical preparations, biologics, drug products, DNA plasmids, advanced therapeutic medicinal products (ATMPs), principally cell and gene therapies intended for research, clinical and commercial use in humans for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting; production of cell lines for others using lentivirus technology
42 Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services in the field of production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research
CENTER FOR BREAKTHROUGH MEDICINES

Trademark Events
Oct 14, 2022
New Application Entered
Oct 26, 2022
New Application Office Supplied Data Entered
Mar 27, 2023
Assigned To Examiner
Mar 28, 2023
Non-Final Action Written
Mar 28, 2023
Non-Final Action E-Mailed
Mar 28, 2023
Notification Of Non-Final Action E-Mailed
Apr 5, 2023
Teas Response To Office Action Received
Apr 5, 2023
Correspondence Received In Law Office
Apr 5, 2023
Teas/Email Correspondence Entered
Apr 6, 2023
Suspension Letter Written
Apr 6, 2023
Letter Of Suspension E-Mailed
Apr 6, 2023
Notification Of Letter Of Suspension E-Mailed
Apr 13, 2023
Teas Response To Suspension Inquiry Received
Aug 26, 2023
Assigned To Lie
Aug 26, 2023
Correspondence Received In Law Office
Aug 26, 2023
Teas/Email Correspondence Entered
Aug 29, 2023
Approved For Pub - Principal Register
Sep 13, 2023
Notification Of Notice Of Publication E-Mailed
Oct 3, 2023
Published For Opposition
Oct 3, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 28, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 1, 2024
Abandonment - No Use Statement Filed
Jul 12, 2024
Abandonment Notice E-Mailed - No Use Statement Filed

Trademark Alertz updated from USPTO on 2030-01-24